Literature DB >> 17266198

Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening.

Michael J Orsini1, Mark A Klein, Mary Pat Beavers, Peter J Connolly, Steven A Middleton, Kevin H Mayo.   

Abstract

Metastin, also known as KiSS-1, the cognate ligand for the metastin receptor GPR54, is a peptide known to dramatically reduce metastasis in experimental models. Despite this, there is no reported structure for metastin nor any small molecule modulators of metastin function that could be used either clinically or experimentally. Here we report the NMR solution structure of a 13-residue metastin peptide in a membrane-like environment (SDS micelles) and find it to have a relatively stable helix conformation from residues 7 to 13. In assays for metastin receptor binding and calcium flux with receptor-transfected HEK-293 cells, we demonstrate through alanine scanning and amino acid substitutions that the peptide C-terminus shows helix periodicity in an NMR structural model and that Phe9, Arg12, and Phe13 are crucial to the activity of the peptide. These three residues lie on one face of the helix and define a pharmacophore site for metastin. We used these pharmacophore features in small molecule database searches to identify hits with submicromolar affinity for the metastin receptor. We also show here that molecules mimicking key elements of this pharmacophore site bind to the metastin receptor and act as full agonists, albeit with reduced potency compared to that of metastin itself. Together this structure-activity approach may yield pharmacologically useful compounds relevant in defining and modulating metastin receptor function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266198     DOI: 10.1021/jm0609824

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Organizational and activational effects of sex steroids on kisspeptin neuron development.

Authors:  Matthew C Poling; Alexander S Kauffman
Journal:  Front Neuroendocrinol       Date:  2012-06-19       Impact factor: 8.606

3.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

4.  Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands.

Authors:  Shinya Oishi; Ryosuke Misu; Kenji Tomita; Shohei Setsuda; Ryo Masuda; Hiroaki Ohno; Yousuke Naniwa; Nahoko Ieda; Naoko Inoue; Satoshi Ohkura; Yoshihisa Uenoyama; Hiroko Tsukamura; Kei-Ichiro Maeda; Akira Hirasawa; Gozoh Tsujimoto; Nobutaka Fujii
Journal:  ACS Med Chem Lett       Date:  2010-10-25       Impact factor: 4.345

5.  A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the G-protein-coupled receptor GPR54.

Authors:  Wendy Kuohung; Maria Burnett; Deepa Mukhtyar; Eli Schuman; Jake Ni; William F Crowley; Marcie A Glicksman; Ursula B Kaiser
Journal:  J Biomol Screen       Date:  2010-05-10

Review 6.  Kisspeptin signaling in the brain.

Authors:  Amy E Oakley; Donald K Clifton; Robert A Steiner
Journal:  Endocr Rev       Date:  2009-09-21       Impact factor: 19.871

7.  Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation.

Authors:  Antonia K Roseweir; Alexander S Kauffman; Jeremy T Smith; Kathryn A Guerriero; Kevin Morgan; Justyna Pielecka-Fortuna; Rafael Pineda; Michelle L Gottsch; Manuel Tena-Sempere; Suzanne M Moenter; Ei Terasawa; Iain J Clarke; Robert A Steiner; Robert P Millar
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

Review 8.  Current and future applications of GnRH, kisspeptin and neurokinin B analogues.

Authors:  Robert P Millar; Claire L Newton
Journal:  Nat Rev Endocrinol       Date:  2013-07-02       Impact factor: 43.330

Review 9.  The role of metastasis suppressor genes in metastatic dormancy.

Authors:  Christine E Horak; Jong Heun Lee; Jean-Claude Marshall; S Martin Shreeve; Patricia S Steeg
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

10.  A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10.

Authors:  Annette E Curtis; Jennifer H Cooke; Jordan E Baxter; James R C Parkinson; Attia Bataveljic; Mohammad A Ghatei; Stephen R Bloom; Kevin G Murphy
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.